Juvenile white shrimp Litopenaeus vannamei (1.98 ± 0.28 g) were fed a commercial diet for 8 wk in triplicate to investigate growth and lipid metabolism at 3 salinities (3, 17, and 30). Shrimp weight gain and survival at 3 were significantly less than that at 17 and 30. No differences were found in whole-body proximate composition. Linolenic acid (18:3[n-3]) and (n-3) long-chain unsaturated fatty acid levels in the hepatopancreas, and n-3 long-chain polyunsaturated fatty acid level, especially eicosapentaenoic acid (EPA; C20:5[n-3]) and docosahexaenoic acid (DHA; C22:6[n-3]) in muscle at 3 were significantly greater than at other salinities. Fatty acid synthase, hormone sensitive lipase, lipoprotein lipase, adipose triacylglycerol lipase, acyl-CoA, diacylglycerol acyltransferase 2, elongase of very long-chain fatty acid 6, and Δ5 and Δ6 fatty acid desaturase activity was detected and showed a negative trend with an increase of salinity, and no significant differences were found among salinity groups (P > 0.05). The results indicate that the low salinity of 3 decreases the growth of L. vannamei. Although L. vannamei could not synthesize either DHA or EPA de novo, it possibly has the potential ability to convert linolenic acid to DHA and EPA regardless of salinity. However, the factors influencing this ability remain unknown and need further study.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 33 • No. 3